sb 202190 has been researched along with Bipolar Disorder in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, JS | 1 |
| Ertley, RN | 1 |
| Lee, HJ | 1 |
| DeMar, JC | 1 |
| Arnold, JT | 1 |
| Rapoport, SI | 1 |
| Bazinet, RP | 1 |
1 other study available for sb 202190 and Bipolar Disorder
| Article | Year |
|---|---|
n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism.
Topics: Animals; Astrocytes; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cell Nucleus; Cells, Cultu | 2007 |